Why is REMS a better technology for bone health?
What is REMS?
REMS (Radiofrequency Echographic Multi-Spectrometry) is a non-invasive, radiation-free technology using ultrasound. This FDA-approved technology measures bone mineral density (BMD) and T-scores like DXA, but also assesses bone quality and microarchitecture. It provides a Fragility Score, a better predictor of future fractures, and combines these data for a comprehensive report including a five-year fracture risk assessment. The REMS instant report advances the diagnostic standard for bone health by offering a holistic view of bone quality and strength.
Advantages over DXA
-
No Radiation: Utilizes safe ultrasound technology, avoiding ionizing radiation.
-
Higher Accuracy: Offers about 5X better accuracy, repeatability, and sensitivity compared to DXA scans.
-
Artifact Elimination: REMS data remains unaffected by conditions like scoliosis, osteoarthritis, or implants.
-
Frequent Monitoring: Safe for regular use, facilitating ongoing assessment of lifestyle changes and treatments.
-
Osteoporosis Prevention: Suitable for younger adults (21+) at risk due to factors like restricted diets, nutrient absorption issues, and medications like chemotherapy, HIV drugs or PPI's (antacids).
-
Convenience: The scan requires no insurance and is $225. Quick and comfortable, with scans completed in minutes and an instant report.